{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T18:50:29Z","timestamp":1710701429903},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s11926-020-00908-5","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T21:02:27Z","timestamp":1590008547000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clusters in Pediatric Rheumatic Diseases"],"prefix":"10.1007","volume":"22","author":[{"given":"Erdal","family":"Sag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selcan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"issue":"1","key":"908_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1\u201311.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"908_CR2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.berh.2017.11.009","volume":"31","author":"E Sag","year":"2017","unstructured":"Sag E, Batu ED, Ozen S. Childhood systemic vasculitis. Best Pract Res Clin Rheumatol. 2017;31(4):558\u201375.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"908_CR3","first-page":"1152","volume":"105","author":"H Behcet","year":"1937","unstructured":"Behcet H. \u00dcber rezidivierende, apht\u00f6se, durch ein virus verursachte Geschw\u00fcre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr. 1937;105:1152\u201363.","journal-title":"Dermatol Wochenschr"},{"key":"908_CR4","doi-asserted-by":"crossref","unstructured":"Criteria for diagnosis of Behcet\u2019s disease. International Study Group for Behcet's Disease. Lancet. 1990;335(8697):1078\u201380.","DOI":"10.1016\/0140-6736(90)92643-V"},{"issue":"6","key":"908_CR5","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/annrheumdis-2015-208491","volume":"75","author":"I Kone-Paut","year":"2016","unstructured":"Kone-Paut I, et al. Consensus classification criteria for paediatric Behcet\u2019s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016;75(6):958\u201364.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 108(6)","key":"908_CR6","first-page":"119","volume":"35","author":"ED Batu","year":"2017","unstructured":"Batu ED, et al. The performance of different classification criteria in paediatric Behcet\u2019s disease. Clin Exp Rheumatol. 2017;35(Suppl 108(6)):119\u201323.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"908_CR7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-3476(99)70333-1","volume":"135","author":"I Kone-Paut","year":"1999","unstructured":"Kone-Paut I, et al. Familial aggregation in Behcet\u2019s disease: high frequency in siblings and parents of pediatric probands. J Pediatr. 1999;135(1):89\u201393.","journal-title":"J Pediatr"},{"issue":"8","key":"908_CR8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/ard.59.8.622","volume":"59","author":"A Gul","year":"2000","unstructured":"Gul A, et al. Familial aggregation of Behcet\u2019s disease in Turkey. Ann Rheum Dis. 2000;59(8):622\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"908_CR9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/09273948.2011.634978","volume":"20","author":"A Gul","year":"2012","unstructured":"Gul A, Ohno S. HLA-B*51 and Behcet disease. Ocul Immunol Inflamm. 2012;20(1):37\u201343.","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"908_CR10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","volume":"45","author":"Y Kirino","year":"2013","unstructured":"Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, et al. Genome-wide association analysis identifies new susceptibility loci for Behcet\u2019s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet. 2013;45(2):202\u20137.","journal-title":"Nat Genet"},{"issue":"8","key":"908_CR11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet\u2019s disease. Nat Genet. 2010;42(8):698\u2013702.","journal-title":"Nat Genet"},{"issue":"11","key":"908_CR12","first-page":"2393","volume":"29","author":"R Tunc","year":"2002","unstructured":"Tunc R, Keyman E, Melikoglu M, Fresko I, Yazici H. Target organ associations in Turkish patients with Behcet\u2019s disease: a cross sectional study by exploratory factor analysis. J Rheumatol. 2002;29(11):2393\u20136.","journal-title":"J Rheumatol"},{"issue":"6","key":"908_CR13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/rheumatology\/ker423","volume":"51","author":"M Karaca","year":"2012","unstructured":"Karaca M, Hatemi G, Sut N, Yazici H. The papulopustular lesion\/arthritis cluster of Behcet\u2019s syndrome also clusters in families. Rheumatology (Oxford). 2012;51(6):1053\u201360.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"908_CR14","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3906\/sag-1605-28","volume":"46","author":"H Yazici","year":"2016","unstructured":"Yazici H, Seyahi E. Behcet syndrome: the vascular cluster. Turk J Med Sci. 2016;46(5):1277\u201380.","journal-title":"Turk J Med Sci"},{"issue":"3","key":"908_CR15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12016-012-8319-x","volume":"43","author":"H Yazici","year":"2012","unstructured":"Yazici H, Ugurlu S, Seyahi E. Behcet syndrome: is it one condition? Clin Rev Allergy Immunol. 2012;43(3):275\u201380.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"908_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","volume":"14","author":"H Yazici","year":"2018","unstructured":"\u2022\u2022 Yazici H, et al. Behcet syndrome: a contemporary view. Nat Rev Rheumatol. 2018;14(2):107\u201319. This is one of the most important review for Behcet disease in the literature.","journal-title":"Nat Rev Rheumatol"},{"key":"908_CR17","unstructured":"Kurosawa M, et al. Sub- group classification of Beh\u00e7et\u2019s disease using clinical information: analysis of a clinical database of patients receiving financial aid for treatment. In The International Society for Beh\u00e7et's Disease (ISBD) Congress 2018. Rotterdam; 2018."},{"key":"908_CR18","doi-asserted-by":"crossref","unstructured":"Sag E, Bilginer Y, Ozen SB, Disease. In: Cimaz R, editor. Periodic and Non-Periodic Fevers. Rare Diseases of the Immune System. Springer, Cham; 2020. p. 161\u201376.","DOI":"10.1007\/978-3-030-19055-2_9"},{"issue":"3","key":"908_CR19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1309\/GCTH-0060-55K8-XCTT","volume":"116","author":"C Demirkesen","year":"2001","unstructured":"Demirkesen C, T\u00fcz\u00fcner N, Mat C, Senocak M, B\u00fcy\u00fckbabani N, T\u00fcz\u00fcn Y, et al. Clinicopathologic evaluation of nodular cutaneous lesions of Behcet syndrome. Am J Clin Pathol. 2001;116(3):341\u20136.","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"908_CR20","first-page":"808","volume":"77","author":"G Hatemi","year":"2018","unstructured":"Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, et al. 2018 update of the EULAR recommendations for the management of Behcet\u2019s syndrome. Ann Rheum Dis. 2018;77(6):808\u201318.","journal-title":"Ann Rheum Dis"},{"issue":"20","key":"908_CR21","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1816594","volume":"381","author":"G Hatemi","year":"2019","unstructured":"Hatemi G, Mahr A, Ishigatsubo Y, Song YW, Takeno M, Kim D, et al. Trial of apremilast for oral ulcers in Behcet\u2019s syndrome. N Engl J Med. 2019;381(20):1918\u201328.","journal-title":"N Engl J Med"},{"issue":"4","key":"908_CR22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-3476(98)70368-3","volume":"132","author":"I Kone-Paut","year":"1998","unstructured":"Kone-Paut I, et al. Clinical features of Behcet\u2019s disease in children: an international collaborative study of 86 cases. J Pediatr. 1998;132(4):721\u20135.","journal-title":"J Pediatr"},{"issue":"5","key":"908_CR23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11739-019-02046-y","volume":"14","author":"E Seyahi","year":"2019","unstructured":"\u2022\u2022 Seyahi E. Phenotypes in Behcet's syndrome. Intern Emerg Med. 2019;14(5):677\u201389. This review nicely describes different phenotypes and clusters in Behcet disease.","journal-title":"Intern Emerg Med"},{"issue":"Suppl 108(6)","key":"908_CR24","first-page":"124","volume":"35","author":"HE Sonmez","year":"2017","unstructured":"Sonmez HE, et al. Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy. Clin Exp Rheumatol. 2017;35(Suppl 108(6)):124\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"908_CR25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/art.23450","volume":"58","author":"G Hatemi","year":"2008","unstructured":"Hatemi G, Fresko I, Tascilar K, Yazici H. Increased enthesopathy among Behcet\u2019s syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum. 2008;58(5):1539\u201345.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"908_CR26","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/ard.60.11.1074","volume":"60","author":"E Diri","year":"2001","unstructured":"Diri E, et al. Papulopustular skin lesions are seen more frequently in patients with Behcet\u2019s syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis. 2001;60(11):1074\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"908_CR27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bjo.2007.137141","volume":"93","author":"GK Sungur","year":"2009","unstructured":"Sungur GK, Hazirolan D, Yalvac I, Ozer PA, Yuksel D, Vural ET, et al. Clinical and demographic evaluation of Behcet disease among different paediatric age groups. Br J Ophthalmol. 2009;93(1):83\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"908_CR28","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.rdc.2013.05.005","volume":"39","author":"A Reiff","year":"2013","unstructured":"Reiff A, Kadayifcilar S, Ozen S. Rheumatic inflammatory eye diseases of childhood. Rheum Dis Clin N Am. 2013;39(4):801\u201332.","journal-title":"Rheum Dis Clin N Am"},{"issue":"3","key":"908_CR29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","volume":"138","author":"I Tugal-Tutkun","year":"2004","unstructured":"Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138(3):373\u201380.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"908_CR30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/14397595.2018.1457424","volume":"29","author":"A Suwa","year":"2019","unstructured":"Suwa A, Horita N, Ishido T, Takeuchi M, Kawagoe T, Shibuya E, et al. The ocular involvement did not accompany with the genital ulcer or the gastrointestinal symptoms at the early stage of Behcet\u2019s disease. Mod Rheumatol. 2019;29(2):357\u201362.","journal-title":"Mod Rheumatol"},{"key":"908_CR31","doi-asserted-by":"crossref","first-page":"9518065","DOI":"10.1155\/2018\/9518065","volume":"2018","author":"MA Hussein","year":"2018","unstructured":"Hussein MA, Eissa IM, Dahab AA. Vision-threatening Behcet\u2019s disease: severity of ocular involvement predictors. J Ophthalmol. 2018;2018:9518065.","journal-title":"J Ophthalmol"},{"issue":"4","key":"908_CR32","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/14397595.2018.1494501","volume":"29","author":"T Suzuki","year":"2019","unstructured":"Suzuki T, Horita N, Takeuchi M, Ishido T, Mizuki Y, Mizuki R, et al. Clinical features of early-stage possible Behcet\u2019s disease patients with a variant-type major organ involvement in Japan. Mod Rheumatol. 2019;29(4):640\u20136.","journal-title":"Mod Rheumatol"},{"issue":"16","key":"908_CR33","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003348","volume":"95","author":"I Hatemi","year":"2016","unstructured":"Hatemi I, Esatoglu SN, Hatemi G, Erzin Y, Yazici H, Celik AF. Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet\u2019s syndrome: a strobe-compliant observational study from a dedicated multidisciplinary center. Medicine (Baltimore). 2016;95(16):e3348.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"908_CR34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12969-016-0070-z","volume":"14","author":"I Kone-Paut","year":"2016","unstructured":"Kone-Paut I. Behcet\u2019s disease in children, an overview. Pediatr Rheumatol Online J. 2016;14(1):10.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"908_CR35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12969-017-0213-x","volume":"15","author":"R Gallizzi","year":"2017","unstructured":"Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, et al. A national cohort study on pediatric Behcet\u2019s disease: cross-sectional data from an Italian registry. Pediatr Rheumatol Online J. 2017;15(1):84.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"908_CR36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MD.0b013e318242ff37","volume":"91","author":"E Seyahi","year":"2012","unstructured":"Seyahi E, Melikoglu M, Akman C, Hamuryudan V, Ozer H, Hatemi G, et al. Pulmonary artery involvement and associated lung disease in Behcet disease: a series of 47 patients. Medicine (Baltimore). 2012;91(1):35\u201348.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"908_CR37","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/rheumatology\/keu233","volume":"53","author":"K Tascilar","year":"2014","unstructured":"Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H. Vascular involvement in Behcet\u2019s syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford). 2014;53(11):2018\u201322.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"908_CR38","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1378\/chest.127.6.2243","volume":"127","author":"O Uzun","year":"2005","unstructured":"Uzun O, Akpolat T, Erkan L. Pulmonary vasculitis in Behcet disease: a cumulative analysis. Chest. 2005;127(6):2243\u201353.","journal-title":"Chest"},{"issue":"2","key":"908_CR39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3899\/jrheum.100257","volume":"38","author":"B Krupa","year":"2011","unstructured":"Krupa B, et al. Pediatric Behcet\u2019s disease and thromboses. J Rheumatol. 2011;38(2):387\u201390.","journal-title":"J Rheumatol"},{"issue":"10","key":"908_CR40","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s10067-016-3187-z","volume":"35","author":"S Nanthapisal","year":"2016","unstructured":"Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA. Paediatric Behcet\u2019s disease: a UK tertiary Centre experience. Clin Rheumatol. 2016;35(10):2509\u201316.","journal-title":"Clin Rheumatol"},{"issue":"1\u20132","key":"908_CR41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-007-8064-8","volume":"35","author":"M Melikoglu","year":"2008","unstructured":"Melikoglu M, Kural-Seyahi E, Tascilar K, Yazici H. The unique features of vasculitis in Behcet\u2019s syndrome. Clin Rev Allergy Immunol. 2008;35(1\u20132):40\u20136.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"908_CR42","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/ard.2003.018515","volume":"63","author":"R Tunc","year":"2004","unstructured":"Tunc R, Saip S, Siva A, Yazici H. Cerebral venous thrombosis is associated with major vessel disease in Behcet\u2019s syndrome. Ann Rheum Dis. 2004;63(12):1693\u20134.","journal-title":"Ann Rheum Dis"},{"key":"908_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","volume":"96","author":"A Fava","year":"2019","unstructured":"Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1\u201313.","journal-title":"J Autoimmun"},{"issue":"12","key":"908_CR44","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","volume":"12","author":"GC Tsokos","year":"2016","unstructured":"Tsokos GC, Lo MS, Reis PC, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716\u201330.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"908_CR45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.autrev.2011.10.020","volume":"11","author":"N Agmon-Levin","year":"2012","unstructured":"Agmon-Levin N, Mosca M, Petri M, Shoenfeld Y. Systemic lupus erythematosus one disease or many? Autoimmun Rev. 2012;11(8):593\u20135.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"908_CR46","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","volume":"165","author":"R Banchereau","year":"2016","unstructured":"Banchereau R, Hong S, Cantarel B, Baldwin N, Baisch J, Edens M, et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell. 2016;165(3):551\u201365.","journal-title":"Cell"},{"issue":"5","key":"908_CR47","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/art.1780330505","volume":"33","author":"EJ ter Borg","year":"1990","unstructured":"ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CGM. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum. 1990;33(5):634\u201343.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"908_CR48","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1136\/ard.2003.013417","volume":"63","author":"IE Hoffman","year":"2004","unstructured":"Hoffman IE, Peene I, Meheus L, Huizinga TW, Cebecauer L, Isenberg D, et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis. 2004;63(9):1155\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"908_CR49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0049-0172(90)90057-M","volume":"20","author":"EJ ter Borg","year":"1990","unstructured":"ter Borg EJ, Groen H, Horst G, Limburg PC, Wouda AA, Kallenberg CGM. Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 1990;20(3):164\u201373.","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"908_CR50","first-page":"2531","volume":"29","author":"E Somers","year":"2002","unstructured":"Somers E, Magder LS, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol. 2002;29(12):2531\u20136.","journal-title":"J Rheumatol"},{"issue":"12","key":"908_CR51","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1002\/art.21414","volume":"52","author":"CH To","year":"2005","unstructured":"To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum. 2005;52(12):4003\u201310.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"908_CR52","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1191\/096120300678828604","volume":"9","author":"FJ Tapanes","year":"2000","unstructured":"Tapanes FJ, Vdsquez M, Ramirez R, Matheus C, Rodriguez MA, Bianco N. Cluster analysis of antinuclear autoantibodies in the prognosis of SLE nephropathy: are anti-extractable nuclear antibodies protective? Lupus. 2000;9(6):437\u201344.","journal-title":"Lupus"},{"issue":"7","key":"908_CR53","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3899\/jrheum.130984","volume":"41","author":"B Artim-Esen","year":"2014","unstructured":"Artim-Esen B, \u00c7ene E, \u015eahinkaya Y, Ertan S, Pehlivan \u00d6, Kamali S, et al. Cluster analysis of autoantibodies in 852 patients with systemic lupus erythematosus from a single center. J Rheumatol. 2014;41(7):1304\u201310.","journal-title":"J Rheumatol"},{"issue":"2","key":"908_CR54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-199303000-00005","volume":"72","author":"R Cervera","year":"1993","unstructured":"Cervera R, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore). 1993;72(2):113\u201324.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"908_CR55","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/0961203307083365","volume":"16","author":"S Malik","year":"2007","unstructured":"Malik S, Bruner GR, Williams-Weese C, Feo L, Hal Scofield R, Reichlin M, et al. Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients. Lupus. 2007;16(11):863\u20136.","journal-title":"Lupus"},{"issue":"2","key":"908_CR56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/jaut.2000.0402","volume":"15","author":"D Alarcon-Segovia","year":"2000","unstructured":"Alarcon-Segovia D, Perez-Ruiz A, Villa AR. Long-term prognosis of antiphospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun. 2000;15(2):157\u201361.","journal-title":"J Autoimmun"},{"issue":"3","key":"908_CR57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0002-9343(99)00413-1","volume":"108","author":"SI Kokori","year":"2000","unstructured":"Kokori SI, et al. Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am J Med. 2000;108(3):198\u2013204.","journal-title":"Am J Med"},{"issue":"3","key":"908_CR58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/qjmed\/93.3.169","volume":"93","author":"FB Karassa","year":"2000","unstructured":"Karassa FB, Ioannidis JP, Touloumi G, Boki KA, Moutsopoulos HM. Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM. 2000;93(3):169\u201374.","journal-title":"QJM"},{"issue":"4","key":"908_CR59","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0002-9343(89)90335-5","volume":"86","author":"RA Asherson","year":"1989","unstructured":"Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O, Baguley E, et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med. 1989;86(4):391\u20139.","journal-title":"Am J Med"},{"issue":"4","key":"908_CR60","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O","volume":"42","author":"JG Hanly","year":"1999","unstructured":"Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum. 1999;42(4):728\u201334.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"908_CR61","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/art.23098","volume":"57","author":"P Tomietto","year":"2007","unstructured":"Tomietto P, Annese V, D'agostini S, Venturini P, la Torre G, de Vita S, et al. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Rheum. 2007;57(8):1461\u201372.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"908_CR62","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3899\/jrheum.140027","volume":"41","author":"EJ Zirkzee","year":"2014","unstructured":"Zirkzee EJ, et al. Cluster analysis of an array of autoantibodies in neuropsychiatric systemic lupus erythematosus. J Rheumatol. 2014;41(8):1720\u20131.","journal-title":"J Rheumatol"},{"issue":"1","key":"908_CR63","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13075-018-1666-0","volume":"20","author":"JA Reynolds","year":"2018","unstructured":"Reynolds JA, McCarthy EM, Haque S, Ngamjanyaporn P, Sergeant JC, Lee E, et al. Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations. Arthritis Res Ther. 2018;20(1):173.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"908_CR64","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12967-017-1345-y","volume":"15","author":"Y Pacheco","year":"2017","unstructured":"Pacheco Y, Barahona-Correa J, Monsalve DM, Acosta-Ampudia Y, Rojas M, Rodr\u00edguez Y, et al. Cytokine and autoantibody clusters interaction in systemic lupus erythematosus. J Transl Med. 2017;15(1):239.","journal-title":"J Transl Med"},{"issue":"6","key":"908_CR65","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.semarthrit.2018.09.005","volume":"48","author":"V Torrente-Segarra","year":"2019","unstructured":"Torrente-Segarra V, Salman Monte TC, R\u00faa-Figueroa I, de U\u00f1a-\u00c1lvarez J, Balboa-Barreiro V, L\u00f3pez-Longo FJ, et al. Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Semin Arthritis Rheum. 2019;48(6):1025\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"908_CR66","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/1756-185X.13745","volume":"23","author":"GY Ahn","year":"2020","unstructured":"Ahn GY, Lee J, Won S, Ha E, Kim H, Nam B, et al. Identifying damage clusters in patients with systemic lupus erythematosus. Int J Rheum Dis. 2020;23(1):84\u201391.","journal-title":"Int J Rheum Dis"},{"issue":"10","key":"908_CR67","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370(10):911\u201320.","journal-title":"N Engl J Med"},{"issue":"5","key":"908_CR68","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","volume":"38","author":"I Meyts","year":"2018","unstructured":"Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018;38(5):569\u201378.","journal-title":"J Clin Immunol"},{"key":"908_CR69","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Lee PY, Kellner ES, Huang Y, Furutani E, Huang Z, Bainter W, et al. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). J Allergy Clin Immunol. 2020;6479(20):30030\u20130. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.908. This study perfectly reports the genotype-phenotype correlations of DADA2 patients.","DOI":"10.1016\/j.jaci.2019.12.908"},{"issue":"10","key":"908_CR70","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"P Navon Elkan","year":"2014","unstructured":"Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370(10):921\u201331.","journal-title":"N Engl J Med"},{"key":"908_CR71","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fped.2018.00282","volume":"6","author":"PY Lee","year":"2018","unstructured":"Lee PY. Vasculopathy, immunodeficiency, and bone marrow failure: the intriguing syndrome caused by deficiency of adenosine deaminase 2. Front Pediatr. 2018;6:282.","journal-title":"Front Pediatr"},{"issue":"1","key":"908_CR72","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3899\/jrheum.181384","volume":"47","author":"S Ozen","year":"2020","unstructured":"\u2022\u2022 Ozen S, et al. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2. J Rheumatol. 2020;47(1):117\u201325. This study reports two distinct phenotype of DADA2 and the major differences between these phenotypes in relatively large number of patients.","journal-title":"J Rheumatol"},{"issue":"1","key":"908_CR73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/BOR.0000000000000669","volume":"32","author":"S Sahin","year":"2020","unstructured":"Sahin S, Adrovic A, Kasapcopur O. A monogenic autoinflammatory disease with fatal vasculitis: deficiency of adenosine deaminase 2. Curr Opin Rheumatol. 2020;32(1):3\u201314.","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"908_CR74","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","volume":"76","author":"R Caorsi","year":"2017","unstructured":"Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis. 2017;76(10):1648\u201356.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"908_CR75","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/jamadermatol.2015.1635","volume":"151","author":"TM Gonzalez Santiago","year":"2015","unstructured":"Gonzalez Santiago TM, Zavialov A, Saarela J, Seppanen M, Reed AM, Abraham RS, et al. Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa. JAMA Dermatol. 2015;151(11):1230\u20134.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"908_CR76","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.2018892752","volume":"134","author":"C Carmona-Rivera","year":"2019","unstructured":"Carmona-Rivera C, Khaznadar SS, Shwin KW, Irizarry-Caro JA, O\u2019Neil LJ, Liu Y, et al. Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2. Blood. 2019;134(4):395\u2013406.","journal-title":"Blood"},{"issue":"16","key":"908_CR77","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJMc1801927","volume":"380","author":"AK Ombrello","year":"2019","unstructured":"Ombrello AK, Qin J, Hoffmann PM, Kumar P, Stone D, Jones A, et al. Treatment strategies for deficiency of adenosine deaminase 2. N Engl J Med. 2019;380(16):1582\u20134.","journal-title":"N Engl J Med"},{"issue":"24","key":"908_CR78","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1182\/blood-2017-07-798660","volume":"130","author":"H Hashem","year":"2017","unstructured":"Hashem H, Kumar AR, M\u00fcller I, Babor F, Bredius R, Dalal J, et al. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood. 2017;130(24):2682\u20138.","journal-title":"Blood"},{"issue":"10","key":"908_CR79","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/rheumatology\/kez016","volume":"58","author":"S Deshayes","year":"2019","unstructured":"\u2022 Deshayes S, et al. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification. Rheumatology (Oxford). 2019;58(10):1731\u20139. This study offers to subgroup AAV according to disease phenotype and antibody associations.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"908_CR80","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/rheumatology\/kez148","volume":"58","author":"A Mahr","year":"2019","unstructured":"Mahr A, Specks U, Jayne D. Subclassifying ANCA-associated vasculitis: a unifying view of disease spectrum. Rheumatology (Oxford). 2019;58(10):1707\u20139.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00908-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-020-00908-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00908-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T07:54:51Z","timestamp":1621497291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-020-00908-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["908"],"URL":"https:\/\/doi.org\/10.1007\/s11926-020-00908-5","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"assertion":[{"value":"20 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"28"}}